nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—NTRK1—bipolar disorder	0.722	1	CbGaD
Regorafenib—RET—autonomic nervous system—bipolar disorder	0.00719	0.0667	CbGeAlD
Regorafenib—UGT1A1—urine—bipolar disorder	0.00461	0.0428	CbGeAlD
Regorafenib—DDR2—adrenal cortex—bipolar disorder	0.00289	0.0268	CbGeAlD
Regorafenib—FLT1—blood plasma—bipolar disorder	0.00269	0.025	CbGeAlD
Regorafenib—CYP2C19—urine—bipolar disorder	0.0025	0.0232	CbGeAlD
Regorafenib—UGT1A1—blood plasma—bipolar disorder	0.00241	0.0223	CbGeAlD
Regorafenib—KDR—blood plasma—bipolar disorder	0.00228	0.0211	CbGeAlD
Regorafenib—KIT—blood plasma—bipolar disorder	0.00202	0.0187	CbGeAlD
Regorafenib—DDR2—thyroid gland—bipolar disorder	0.00201	0.0187	CbGeAlD
Regorafenib—EPHX2—adrenal cortex—bipolar disorder	0.00195	0.0181	CbGeAlD
Regorafenib—CYP2C9—urine—bipolar disorder	0.00194	0.018	CbGeAlD
Regorafenib—MAPK11—thyroid gland—bipolar disorder	0.00191	0.0177	CbGeAlD
Regorafenib—Sorafenib—HTR2C—bipolar disorder	0.0019	1	CrCbGaD
Regorafenib—FLT4—adrenal cortex—bipolar disorder	0.00176	0.0163	CbGeAlD
Regorafenib—DDR2—nervous system—bipolar disorder	0.00169	0.0157	CbGeAlD
Regorafenib—MAPK11—nervous system—bipolar disorder	0.0016	0.0149	CbGeAlD
Regorafenib—DDR2—cerebellum—bipolar disorder	0.00159	0.0148	CbGeAlD
Regorafenib—MAPK11—cerebellum—bipolar disorder	0.00151	0.014	CbGeAlD
Regorafenib—CYP3A4—urine—bipolar disorder	0.00148	0.0137	CbGeAlD
Regorafenib—EPHA2—adrenal cortex—bipolar disorder	0.00145	0.0135	CbGeAlD
Regorafenib—BRAF—thyroid gland—bipolar disorder	0.00142	0.0132	CbGeAlD
Regorafenib—TEK—adrenal cortex—bipolar disorder	0.00141	0.0131	CbGeAlD
Regorafenib—FLT1—adrenal cortex—bipolar disorder	0.00137	0.0127	CbGeAlD
Regorafenib—RAF1—adrenal cortex—bipolar disorder	0.00136	0.0126	CbGeAlD
Regorafenib—EPHX2—thyroid gland—bipolar disorder	0.00136	0.0126	CbGeAlD
Regorafenib—CYP2C19—blood plasma—bipolar disorder	0.00131	0.0121	CbGeAlD
Regorafenib—DDR2—brain—bipolar disorder	0.00129	0.012	CbGeAlD
Regorafenib—MAPK11—brain—bipolar disorder	0.00123	0.0114	CbGeAlD
Regorafenib—FLT4—thyroid gland—bipolar disorder	0.00122	0.0114	CbGeAlD
Regorafenib—FGFR1—thyroid gland—bipolar disorder	0.00121	0.0112	CbGeAlD
Regorafenib—KDR—adrenal cortex—bipolar disorder	0.00116	0.0107	CbGeAlD
Regorafenib—CYP2C8—blood plasma—bipolar disorder	0.00114	0.0106	CbGeAlD
Regorafenib—BRAF—cerebellum—bipolar disorder	0.00112	0.0104	CbGeAlD
Regorafenib—RET—thyroid gland—bipolar disorder	0.00108	0.01	CbGeAlD
Regorafenib—EPHX2—cerebellum—bipolar disorder	0.00108	0.00998	CbGeAlD
Regorafenib—FGFR2—thyroid gland—bipolar disorder	0.00103	0.00954	CbGeAlD
Regorafenib—CYP2B6—blood plasma—bipolar disorder	0.00102	0.00948	CbGeAlD
Regorafenib—CYP2C9—blood plasma—bipolar disorder	0.00101	0.00939	CbGeAlD
Regorafenib—EPHA2—thyroid gland—bipolar disorder	0.00101	0.00937	CbGeAlD
Regorafenib—PDGFRB—adrenal cortex—bipolar disorder	0.001	0.00928	CbGeAlD
Regorafenib—TEK—thyroid gland—bipolar disorder	0.000985	0.00914	CbGeAlD
Regorafenib—FGFR1—cerebellum—bipolar disorder	0.000956	0.00888	CbGeAlD
Regorafenib—FLT1—thyroid gland—bipolar disorder	0.000952	0.00884	CbGeAlD
Regorafenib—RAF1—thyroid gland—bipolar disorder	0.000947	0.00879	CbGeAlD
Regorafenib—BRAF—brain—bipolar disorder	0.000914	0.00848	CbGeAlD
Regorafenib—RET—nervous system—bipolar disorder	0.00091	0.00844	CbGeAlD
Regorafenib—PDGFRA—thyroid gland—bipolar disorder	0.000892	0.00828	CbGeAlD
Regorafenib—ABL1—adrenal cortex—bipolar disorder	0.000892	0.00828	CbGeAlD
Regorafenib—EPHX2—brain—bipolar disorder	0.000873	0.0081	CbGeAlD
Regorafenib—FGFR2—nervous system—bipolar disorder	0.000864	0.00802	CbGeAlD
Regorafenib—RET—cerebellum—bipolar disorder	0.000856	0.00794	CbGeAlD
Regorafenib—EPHA2—nervous system—bipolar disorder	0.000849	0.00788	CbGeAlD
Regorafenib—TEK—nervous system—bipolar disorder	0.000829	0.00769	CbGeAlD
Regorafenib—FGFR2—cerebellum—bipolar disorder	0.000813	0.00755	CbGeAlD
Regorafenib—KDR—thyroid gland—bipolar disorder	0.000805	0.00747	CbGeAlD
Regorafenib—FLT1—nervous system—bipolar disorder	0.000801	0.00743	CbGeAlD
Regorafenib—RAF1—nervous system—bipolar disorder	0.000796	0.00739	CbGeAlD
Regorafenib—FLT4—brain—bipolar disorder	0.000788	0.00731	CbGeAlD
Regorafenib—TEK—cerebellum—bipolar disorder	0.00078	0.00724	CbGeAlD
Regorafenib—FGFR1—brain—bipolar disorder	0.000777	0.00721	CbGeAlD
Regorafenib—CYP3A4—blood plasma—bipolar disorder	0.000772	0.00716	CbGeAlD
Regorafenib—FLT1—cerebellum—bipolar disorder	0.000754	0.007	CbGeAlD
Regorafenib—PDGFRA—nervous system—bipolar disorder	0.000751	0.00697	CbGeAlD
Regorafenib—RAF1—cerebellum—bipolar disorder	0.000749	0.00696	CbGeAlD
Regorafenib—KIT—thyroid gland—bipolar disorder	0.000713	0.00662	CbGeAlD
Regorafenib—PDGFRA—cerebellum—bipolar disorder	0.000706	0.00656	CbGeAlD
Regorafenib—PDGFRB—thyroid gland—bipolar disorder	0.000697	0.00647	CbGeAlD
Regorafenib—RET—brain—bipolar disorder	0.000695	0.00645	CbGeAlD
Regorafenib—KDR—nervous system—bipolar disorder	0.000677	0.00628	CbGeAlD
Regorafenib—FGFR2—brain—bipolar disorder	0.000661	0.00613	CbGeAlD
Regorafenib—EPHA2—brain—bipolar disorder	0.000649	0.00602	CbGeAlD
Regorafenib—KDR—cerebellum—bipolar disorder	0.000637	0.00591	CbGeAlD
Regorafenib—TEK—brain—bipolar disorder	0.000633	0.00588	CbGeAlD
Regorafenib—ABL1—thyroid gland—bipolar disorder	0.000621	0.00576	CbGeAlD
Regorafenib—FLT1—brain—bipolar disorder	0.000612	0.00568	CbGeAlD
Regorafenib—RAF1—brain—bipolar disorder	0.000609	0.00565	CbGeAlD
Regorafenib—KIT—nervous system—bipolar disorder	0.0006	0.00557	CbGeAlD
Regorafenib—PDGFRB—nervous system—bipolar disorder	0.000586	0.00544	CbGeAlD
Regorafenib—PDGFRA—brain—bipolar disorder	0.000574	0.00533	CbGeAlD
Regorafenib—KIT—cerebellum—bipolar disorder	0.000565	0.00524	CbGeAlD
Regorafenib—ABCG2—adrenal cortex—bipolar disorder	0.000562	0.00522	CbGeAlD
Regorafenib—PDGFRB—cerebellum—bipolar disorder	0.000552	0.00512	CbGeAlD
Regorafenib—ABCB1—blood plasma—bipolar disorder	0.000546	0.00507	CbGeAlD
Regorafenib—ABL1—nervous system—bipolar disorder	0.000522	0.00485	CbGeAlD
Regorafenib—CYP2B6—adrenal cortex—bipolar disorder	0.000519	0.00481	CbGeAlD
Regorafenib—KDR—brain—bipolar disorder	0.000518	0.0048	CbGeAlD
Regorafenib—ABL1—cerebellum—bipolar disorder	0.000492	0.00456	CbGeAlD
Regorafenib—KIT—brain—bipolar disorder	0.000459	0.00426	CbGeAlD
Regorafenib—PDGFRB—brain—bipolar disorder	0.000448	0.00416	CbGeAlD
Regorafenib—ABL1—brain—bipolar disorder	0.000399	0.00371	CbGeAlD
Regorafenib—ABCG2—thyroid gland—bipolar disorder	0.000392	0.00364	CbGeAlD
Regorafenib—ABCG2—cerebellum—bipolar disorder	0.00031	0.00288	CbGeAlD
Regorafenib—CYP2B6—nervous system—bipolar disorder	0.000304	0.00282	CbGeAlD
Regorafenib—ABCB1—adrenal cortex—bipolar disorder	0.000277	0.00257	CbGeAlD
Regorafenib—CYP2C8—brain—bipolar disorder	0.000259	0.0024	CbGeAlD
Regorafenib—ABCG2—brain—bipolar disorder	0.000252	0.00234	CbGeAlD
Regorafenib—CYP2B6—brain—bipolar disorder	0.000232	0.00216	CbGeAlD
Regorafenib—CYP3A4—nervous system—bipolar disorder	0.000229	0.00213	CbGeAlD
Regorafenib—ABCB1—thyroid gland—bipolar disorder	0.000193	0.00179	CbGeAlD
Regorafenib—ABCB1—nervous system—bipolar disorder	0.000162	0.00151	CbGeAlD
Regorafenib—ABCB1—cerebellum—bipolar disorder	0.000153	0.00142	CbGeAlD
Regorafenib—ABCB1—brain—bipolar disorder	0.000124	0.00115	CbGeAlD
Regorafenib—PDGFRB—Signaling Pathways—HTR2C—bipolar disorder	1.42e-05	8.47e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—GSK3B—bipolar disorder	1.41e-05	8.41e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—S100B—bipolar disorder	1.41e-05	8.41e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AKR1C4—bipolar disorder	1.41e-05	8.39e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—ADCY2—bipolar disorder	1.4e-05	8.34e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—ADCY2—bipolar disorder	1.4e-05	8.32e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—HTR2A—bipolar disorder	1.4e-05	8.32e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TCF7L2—bipolar disorder	1.4e-05	8.31e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TCF7L2—bipolar disorder	1.39e-05	8.29e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NR1D1—bipolar disorder	1.39e-05	8.26e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—DRD2—bipolar disorder	1.39e-05	8.26e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—MTHFR—bipolar disorder	1.39e-05	8.25e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NTRK2—bipolar disorder	1.39e-05	8.24e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—DRD2—bipolar disorder	1.38e-05	8.23e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NRG1—bipolar disorder	1.38e-05	8.23e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—MTHFR—bipolar disorder	1.38e-05	8.22e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ADCY2—bipolar disorder	1.38e-05	8.21e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ADCY2—bipolar disorder	1.38e-05	8.21e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD3—bipolar disorder	1.38e-05	8.2e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—GSK3A—bipolar disorder	1.37e-05	8.17e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	1.36e-05	8.1e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NR1D1—bipolar disorder	1.36e-05	8.07e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	1.35e-05	8.05e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NTRK1—bipolar disorder	1.35e-05	8.02e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD4—bipolar disorder	1.34e-05	7.96e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NRG1—bipolar disorder	1.34e-05	7.94e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NCAN—bipolar disorder	1.33e-05	7.91e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NTRK1—bipolar disorder	1.32e-05	7.88e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—SNAP25—bipolar disorder	1.32e-05	7.87e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—HTR2A—bipolar disorder	1.32e-05	7.86e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—HTR2A—bipolar disorder	1.32e-05	7.84e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR1A—bipolar disorder	1.31e-05	7.82e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—S100B—bipolar disorder	1.31e-05	7.8e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SLC5A3—bipolar disorder	1.3e-05	7.74e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—GSK3B—bipolar disorder	1.3e-05	7.73e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NCAN—bipolar disorder	1.3e-05	7.72e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TAC1—bipolar disorder	1.29e-05	7.7e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—GSK3B—bipolar disorder	1.29e-05	7.7e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—S100B—bipolar disorder	1.29e-05	7.66e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—INS—bipolar disorder	1.28e-05	7.59e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—GSK3B—bipolar disorder	1.28e-05	7.59e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SLC5A3—bipolar disorder	1.27e-05	7.56e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD1—bipolar disorder	1.27e-05	7.55e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2C—bipolar disorder	1.27e-05	7.55e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NR1D1—bipolar disorder	1.27e-05	7.54e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—POMC—bipolar disorder	1.26e-05	7.51e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ADCY2—bipolar disorder	1.26e-05	7.5e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NRG1—bipolar disorder	1.26e-05	7.49e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NTRK1—bipolar disorder	1.26e-05	7.47e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TCF7L2—bipolar disorder	1.26e-05	7.47e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NTRK1—bipolar disorder	1.25e-05	7.46e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NRG1—bipolar disorder	1.25e-05	7.42e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—DRD2—bipolar disorder	1.25e-05	7.42e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CLOCK—bipolar disorder	1.25e-05	7.41e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—MTHFR—bipolar disorder	1.25e-05	7.41e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NTRK2—bipolar disorder	1.23e-05	7.34e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—NRG1—bipolar disorder	1.23e-05	7.33e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD3—bipolar disorder	1.23e-05	7.31e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—GSK3A—bipolar disorder	1.22e-05	7.28e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—S100B—bipolar disorder	1.22e-05	7.27e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—S100B—bipolar disorder	1.22e-05	7.25e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—TSHB—bipolar disorder	1.21e-05	7.22e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—TPH2—bipolar disorder	1.21e-05	7.22e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CACNB2—bipolar disorder	1.21e-05	7.22e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NCAN—bipolar disorder	1.21e-05	7.21e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—GSK3B—bipolar disorder	1.21e-05	7.2e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—GSK3B—bipolar disorder	1.21e-05	7.18e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—GSK3B—bipolar disorder	1.2e-05	7.13e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—DPYD—bipolar disorder	1.19e-05	7.1e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD4—bipolar disorder	1.19e-05	7.1e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SLC5A3—bipolar disorder	1.19e-05	7.06e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—INS—bipolar disorder	1.18e-05	7.04e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—COMT—bipolar disorder	1.18e-05	7.03e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—COMT—bipolar disorder	1.18e-05	7.03e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—GSK3B—bipolar disorder	1.18e-05	7e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—MAOA—bipolar disorder	1.17e-05	6.98e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—MAOA—bipolar disorder	1.17e-05	6.98e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ADCY2—bipolar disorder	1.17e-05	6.97e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—INS—bipolar disorder	1.16e-05	6.91e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NRG1—bipolar disorder	1.16e-05	6.88e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NRG1—bipolar disorder	1.14e-05	6.76e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—HTR2A—bipolar disorder	1.14e-05	6.76e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—IMPA1—bipolar disorder	1.13e-05	6.72e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NTRK1—bipolar disorder	1.13e-05	6.72e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—GSK3B—bipolar disorder	1.13e-05	6.69e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—HTR2A—bipolar disorder	1.13e-05	6.69e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ADCY2—bipolar disorder	1.12e-05	6.68e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TCF7L2—bipolar disorder	1.12e-05	6.66e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—GSK3B—bipolar disorder	1.12e-05	6.65e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—POMC—bipolar disorder	1.12e-05	6.64e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—GSK3B—bipolar disorder	1.12e-05	6.63e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—DRD2—bipolar disorder	1.11e-05	6.61e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CACNA1C—bipolar disorder	1.11e-05	6.6e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—INS—bipolar disorder	1.11e-05	6.6e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—MTHFR—bipolar disorder	1.11e-05	6.6e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—INS—bipolar disorder	1.1e-05	6.56e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—INS—bipolar disorder	1.1e-05	6.54e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—S100B—bipolar disorder	1.1e-05	6.53e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—GSK3B—bipolar disorder	1.09e-05	6.47e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3C2A—bipolar disorder	1.08e-05	6.44e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NRG1—bipolar disorder	1.08e-05	6.41e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NRG1—bipolar disorder	1.08e-05	6.4e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—GSK3B—bipolar disorder	1.06e-05	6.33e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—GSK3B—bipolar disorder	1.06e-05	6.31e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—POMC—bipolar disorder	1.06e-05	6.28e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CLOCK—bipolar disorder	1.05e-05	6.27e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—POMC—bipolar disorder	1.05e-05	6.26e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—INS—bipolar disorder	1.05e-05	6.24e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—HTR2A—bipolar disorder	1.04e-05	6.2e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL1B—bipolar disorder	1.04e-05	6.19e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—TPH2—bipolar disorder	1.03e-05	6.11e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—TSHB—bipolar disorder	1.03e-05	6.11e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CACNB2—bipolar disorder	1.03e-05	6.11e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—HTR2A—bipolar disorder	1.02e-05	6.09e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—DPYD—bipolar disorder	1.01e-05	6.01e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NTRK1—bipolar disorder	1.01e-05	5.99e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—GSK3B—bipolar disorder	1e-05	5.97e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—COMT—bipolar disorder	1e-05	5.97e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MAOA—bipolar disorder	9.96e-06	5.93e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—INS—bipolar disorder	9.91e-06	5.89e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—S100B—bipolar disorder	9.79e-06	5.82e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—HTR2A—bipolar disorder	9.72e-06	5.78e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SNAP25—bipolar disorder	9.71e-06	5.77e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—HTR2A—bipolar disorder	9.7e-06	5.77e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—GSK3B—bipolar disorder	9.7e-06	5.77e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NRG1—bipolar disorder	9.69e-06	5.76e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	9.61e-06	5.71e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL1B—bipolar disorder	9.56e-06	5.69e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—MTHFR—bipolar disorder	9.56e-06	5.69e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—MTHFR—bipolar disorder	9.56e-06	5.69e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CLOCK—bipolar disorder	9.42e-06	5.6e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CACNA1C—bipolar disorder	9.4e-06	5.59e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL1B—bipolar disorder	9.39e-06	5.58e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	9.3e-06	5.53e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CLOCK—bipolar disorder	9.19e-06	5.47e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—TSHB—bipolar disorder	9.18e-06	5.46e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—TPH2—bipolar disorder	9.18e-06	5.46e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CACNB2—bipolar disorder	9.18e-06	5.46e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3C2A—bipolar disorder	9.16e-06	5.45e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—GSK3B—bipolar disorder	9.15e-06	5.44e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—POMC—bipolar disorder	9.07e-06	5.4e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—GSK3B—bipolar disorder	9.06e-06	5.39e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	9.04e-06	5.38e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—DPYD—bipolar disorder	9.03e-06	5.37e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—INS—bipolar disorder	9.02e-06	5.37e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—POMC—bipolar disorder	8.99e-06	5.35e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—TSHB—bipolar disorder	8.96e-06	5.33e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—TPH2—bipolar disorder	8.96e-06	5.33e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CACNB2—bipolar disorder	8.96e-06	5.33e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—GSK3B—bipolar disorder	8.95e-06	5.32e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—INS—bipolar disorder	8.94e-06	5.32e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL1B—bipolar disorder	8.91e-06	5.3e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL1B—bipolar disorder	8.89e-06	5.29e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—INS—bipolar disorder	8.83e-06	5.25e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—DPYD—bipolar disorder	8.81e-06	5.24e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—HTR2A—bipolar disorder	8.74e-06	5.2e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NRG1—bipolar disorder	8.64e-06	5.14e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ADCY2—bipolar disorder	8.59e-06	5.11e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CLOCK—bipolar disorder	8.59e-06	5.11e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—GSK3B—bipolar disorder	8.4e-06	4.99e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CACNA1C—bipolar disorder	8.39e-06	4.99e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—TSHB—bipolar disorder	8.37e-06	4.98e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—TPH2—bipolar disorder	8.37e-06	4.98e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CACNB2—bipolar disorder	8.37e-06	4.98e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NR1D1—bipolar disorder	8.36e-06	4.97e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—POMC—bipolar disorder	8.33e-06	4.95e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—INS—bipolar disorder	8.29e-06	4.93e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—GSK3B—bipolar disorder	8.25e-06	4.91e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—DPYD—bipolar disorder	8.23e-06	4.89e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SNAP25—bipolar disorder	8.22e-06	4.89e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CACNA1C—bipolar disorder	8.19e-06	4.87e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—POMC—bipolar disorder	8.18e-06	4.87e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	8.18e-06	4.86e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—INS—bipolar disorder	8.14e-06	4.84e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—MTHFR—bipolar disorder	8.11e-06	4.82e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	8.07e-06	4.8e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL1B—bipolar disorder	8.01e-06	4.76e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NCAN—bipolar disorder	7.99e-06	4.75e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	7.98e-06	4.75e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	7.83e-06	4.66e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—GSK3B—bipolar disorder	7.83e-06	4.66e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—GSK3B—bipolar disorder	7.81e-06	4.64e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL1B—bipolar disorder	7.8e-06	4.64e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—HTR2A—bipolar disorder	7.79e-06	4.63e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—POMC—bipolar disorder	7.77e-06	4.62e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—POMC—bipolar disorder	7.75e-06	4.61e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—INS—bipolar disorder	7.72e-06	4.59e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—INS—bipolar disorder	7.7e-06	4.58e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CACNA1C—bipolar disorder	7.65e-06	4.55e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—POMC—bipolar disorder	7.65e-06	4.55e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—POMC—bipolar disorder	7.65e-06	4.55e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—INS—bipolar disorder	7.6e-06	4.52e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—INS—bipolar disorder	7.6e-06	4.52e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	7.46e-06	4.43e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	7.36e-06	4.38e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—COMT—bipolar disorder	7.36e-06	4.37e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SNAP25—bipolar disorder	7.34e-06	4.36e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MAOA—bipolar disorder	7.3e-06	4.34e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ADCY2—bipolar disorder	7.27e-06	4.33e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SNAP25—bipolar disorder	7.16e-06	4.26e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL1B—bipolar disorder	7.14e-06	4.25e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—GSK3B—bipolar disorder	7.03e-06	4.18e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—POMC—bipolar disorder	6.98e-06	4.15e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—INS—bipolar disorder	6.94e-06	4.13e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SNAP25—bipolar disorder	6.69e-06	3.98e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADCY2—bipolar disorder	6.49e-06	3.86e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—POMC—bipolar disorder	6.49e-06	3.86e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—INS—bipolar disorder	6.45e-06	3.84e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADCY2—bipolar disorder	6.34e-06	3.77e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—GSK3B—bipolar disorder	6.27e-06	3.73e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—COMT—bipolar disorder	6.23e-06	3.7e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—POMC—bipolar disorder	6.22e-06	3.7e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—INS—bipolar disorder	6.18e-06	3.68e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MAOA—bipolar disorder	6.18e-06	3.68e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—MTHFR—bipolar disorder	5.95e-06	3.54e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADCY2—bipolar disorder	5.92e-06	3.52e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CLOCK—bipolar disorder	5.66e-06	3.37e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—COMT—bipolar disorder	5.56e-06	3.31e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MAOA—bipolar disorder	5.52e-06	3.28e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—TSHB—bipolar disorder	5.52e-06	3.28e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—TPH2—bipolar disorder	5.52e-06	3.28e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CACNB2—bipolar disorder	5.52e-06	3.28e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DPYD—bipolar disorder	5.43e-06	3.23e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—COMT—bipolar disorder	5.43e-06	3.23e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MAOA—bipolar disorder	5.39e-06	3.2e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—COMT—bipolar disorder	5.07e-06	3.01e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	5.05e-06	3e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MTHFR—bipolar disorder	5.03e-06	2.99e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MAOA—bipolar disorder	5.03e-06	2.99e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	4.92e-06	2.92e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—bipolar disorder	4.76e-06	2.83e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—INS—bipolar disorder	4.73e-06	2.81e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MTHFR—bipolar disorder	4.49e-06	2.67e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SNAP25—bipolar disorder	4.41e-06	2.62e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MTHFR—bipolar disorder	4.39e-06	2.61e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MTHFR—bipolar disorder	4.1e-06	2.44e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—bipolar disorder	4.03e-06	2.39e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—INS—bipolar disorder	4e-06	2.38e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADCY2—bipolar disorder	3.9e-06	2.32e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—bipolar disorder	3.59e-06	2.14e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—INS—bipolar disorder	3.57e-06	2.13e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—bipolar disorder	3.51e-06	2.09e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—INS—bipolar disorder	3.49e-06	2.07e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—COMT—bipolar disorder	3.34e-06	1.99e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MAOA—bipolar disorder	3.32e-06	1.97e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—bipolar disorder	3.28e-06	1.95e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—INS—bipolar disorder	3.26e-06	1.94e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MTHFR—bipolar disorder	2.7e-06	1.61e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—bipolar disorder	2.16e-06	1.29e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—INS—bipolar disorder	2.15e-06	1.28e-05	CbGpPWpGaD
